The BMJ is an international peer reviewed medical journal and a fully “online first” publication. The BMJ’s vision is to be the world’s most influential and widely read medical journal. Our mission is to lead the debate on health and to engage, inform, and stimulate doctors, researchers, and other health professionals in ways that will improve outcomes for patients. We aim to help doctors to make better decisions.
Manage episode 299212854 series 1426075
A borderline hba1c result will initiate a conversation with a patient - but how useful is that "prediabetes" check-in, and can GPs ever adequately describe what the elevated risk of having a risk factor actually means for a patients health? Our guests in this episode are Sam Finnikin, an academic GP from the University of Birmingham, who gives some helpful tips on explaining that risk, and reminds Tom that fear is not a good motivator of behaviour change. Seamus O'Mahony is a retired gastroenterologist, and author. He explains the process which births a new diagnosis, and why he feels that creeping disease definitions are undermining the medical profession. Further reading A borderline HbA1c result https://www.bmj.com/content/365/bmj.l1361 The epidemic of pre-diabetes: the medicine and the politics https://www.bmj.com/content/349/bmj.g4485 Time to question the NHS diabetes prevention programme https://www.bmj.com/content/351/bmj.h4717